Laboratory studies have found that a combination of THC and CBD can kill ovarian cancer cells without harming healthy cells. Researchers are exploring whether future cancer treatments could be ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Adherence to cervical cancer screening guidelines is low, with more than 60% undergoing overscreening, according to a research letter published online Dec. 10 in JAMA Network Open.

The Maria star, 50, candidly revealed why she's chosen to show the results of her preventive double mastectomyfrom over a ...

Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

ABSTRACT: Background: Ovarian cancer remains the most lethal gynaecological malignancy, with survival closely linked to stage at diagnosis. Cancer antigen 125 (CA 125) is a long-established biomarker ...

ABSTRACT: Background: Ovarian cancer remains the most lethal gynaecological malignancy, with survival closely linked to stage at diagnosis. Cancer antigen 125 (CA 125) is a long-established biomarker ...

Daiichi Sankyo and Merck & Co. have reported midphase ovarian cancer data, clearing the partners to advance the antibody-drug conjugate into the phase 3 part of the trial. The phase 2 trial tested ...

Background: Ovarian cancer complicated with chylothorax is extremely rare, and only eight papers can be searched in PubMed. We report a case of advanced ovarian cancer with extensive lymphatic ...